[1] |
WEI Mingjing, CHEN Wenqi.
Update of TRPV3 in the occurrence and treatment of skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 66-70.
|
[2] |
YANG Xiaoli, DENG Danqi.
Research progress of atopic dermatitis and metabolic syndrome
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 614-618.
|
[3] |
YANG Zijing, PAN Meng, ZHAO Xiaoqing.
Dupilumab-induced immune drifting from atopic dermatitis to polymyalgia rheumatica: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 508-511.
|
[4] |
HONG Anlan, LIN Tong.
Update of the role for TRP channels in inflammatory skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 129-133.
|
[5] |
WU Zhuoxuan, LI Meng, CHEN Jinbo, HU Feng, WANG Xiangdong, QIN Li.
Composition of gut microbiota between infants with atopic dermatitis and healthy infants
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 708-712.
|
[6] |
HE Chun, LI Jingyi.
Atopic dermatitis-like monogenic diseases
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 764-769.
|
[7] |
YAN Hongxia, HUA Ri, JIA Xiujuan, WANG Bailing, GAO Zhiqing, ZHANG Xiaofeng, WU Fenglan, MU Qiri.
Update of TRPV1 in the pathogenesis and treatment of atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 770-773.
|
[8] |
LI Jibing, LI Wei, HU Cui, QIAN Yingying, ZHANG Ting, QIAN Hua.
Effects of climatic factors on the outpatient visits of children's atopic dermatitis in Suzhou
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(1): 11-14.
|
[9] |
HUA Sirui, XU Kejia, WANG Lin.
Effect of ebastine on Balb/c mouse model of atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(6): 355-358.
|
[10] |
CHEN Jing, ZHANG Shoumin.
Update of the study of immunological characteristics and management progress in the study of alopecia areata combined with atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(5): 343-346.
|
[11] |
LI Mengmeng, LI Jingyi, LIU Qingfeng, LIU Youqing, LI Wei.
Clinical efficacy and safety of dupilumab in the treatment of moderate and severe atopic dermatitis for 16 weeks
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(12): 849-852.
|
[12] |
JIANG Fei, ZHAO Qing, SUN Yonghu, ZHANG Zhaoxia, YANG Baoqi, YANG Qing, LIU Guoyan, SHI Zhongxiang, LIU Hong, ZHANG Furen.
Efficacy of dupilumab in 5 children with moderate-to-severe atopic dermatitis: a real-world study
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 790-793.
|
[13] |
WU Zhe, YAO Zhirong.
Update of skin microbiome of common skin diseases in infant
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(3): 185-188.
|
[14] |
HAN Yue, YAO Xu.
Activation and inflammation of HaCaT Cells regulated by exosomes in peripheral blood of the patients with atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(2): 70-74.
|
[15] |
YANG Yan, CHEN Quan, LIU Yumei, ZHOU Xin, TIAN Xin, GAO Aili, XIONG Siying, CHEN Xiaoyin, LI Wei, ZHU Huilan.
Correlation between single nucleotide polymorphisms of IL-33/IL1RL1 genes and atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(11): 649-652.
|